[{"as_of":"2026-09-01","sponsor_name":"Pfizer","sponsor_name_normalized":"pfizer","query_used":"Pfizer","country_code":"USA","n_starts_trailing12m":134,"n_starts_prior12m":140,"n_phase3_trailing12m":35,"n_phase3_prior12m":21,"velocity_pct":-4.29,"phase3_velocity_pct":66.67,"pipeline_score":53.71,"pipeline_rank":4,"momentum_flag":"stable","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Pfizer&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"4d61d8bc6c1c3a6f"},{"as_of":"2026-09-01","sponsor_name":"Merck & Co. (MSD)","sponsor_name_normalized":"merck & co. (msd)","query_used":"Merck Sharp Dohme","country_code":"USA","n_starts_trailing12m":111,"n_starts_prior12m":143,"n_phase3_trailing12m":20,"n_phase3_prior12m":24,"velocity_pct":-22.38,"phase3_velocity_pct":-16.67,"pipeline_score":49.24,"pipeline_rank":12,"momentum_flag":"declining","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Merck+Sharp+Dohme&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"320d5a03c7148ddd"},{"as_of":"2026-09-01","sponsor_name":"Johnson & Johnson","sponsor_name_normalized":"johnson & johnson","query_used":"Johnson Johnson","country_code":"USA","n_starts_trailing12m":27,"n_starts_prior12m":42,"n_phase3_trailing12m":2,"n_phase3_prior12m":0,"velocity_pct":-35.71,"phase3_velocity_pct":null,"pipeline_score":32.54,"pipeline_rank":30,"momentum_flag":"declining","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Johnson+Johnson&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"a3fd4b4c9021bc29"},{"as_of":"2026-09-01","sponsor_name":"Eli Lilly","sponsor_name_normalized":"eli lilly","query_used":"Eli Lilly","country_code":"USA","n_starts_trailing12m":118,"n_starts_prior12m":124,"n_phase3_trailing12m":28,"n_phase3_prior12m":26,"velocity_pct":-4.84,"phase3_velocity_pct":7.69,"pipeline_score":52.28,"pipeline_rank":10,"momentum_flag":"stable","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Eli+Lilly&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"00e08c8958d1281e"},{"as_of":"2026-09-01","sponsor_name":"Bristol Myers Squibb","sponsor_name_normalized":"bristol myers squibb","query_used":"Bristol Myers Squibb","country_code":"USA","n_starts_trailing12m":102,"n_starts_prior12m":90,"n_phase3_trailing12m":20,"n_phase3_prior12m":17,"velocity_pct":13.33,"phase3_velocity_pct":17.65,"pipeline_score":53.21,"pipeline_rank":7,"momentum_flag":"growing","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Bristol+Myers+Squibb&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"7efe0c77820f3f3d"},{"as_of":"2026-09-01","sponsor_name":"AbbVie","sponsor_name_normalized":"abbvie","query_used":"AbbVie","country_code":"USA","n_starts_trailing12m":92,"n_starts_prior12m":99,"n_phase3_trailing12m":13,"n_phase3_prior12m":14,"velocity_pct":-7.07,"phase3_velocity_pct":-7.14,"pipeline_score":49.33,"pipeline_rank":11,"momentum_flag":"stable","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=AbbVie&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"426c216e8373bc97"},{"as_of":"2026-09-01","sponsor_name":"Amgen","sponsor_name_normalized":"amgen","query_used":"Amgen","country_code":"USA","n_starts_trailing12m":46,"n_starts_prior12m":56,"n_phase3_trailing12m":13,"n_phase3_prior12m":15,"velocity_pct":-17.86,"phase3_velocity_pct":-13.33,"pipeline_score":40.54,"pipeline_rank":23,"momentum_flag":"declining","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Amgen&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"057e18a1be75f4f2"},{"as_of":"2026-09-01","sponsor_name":"Gilead Sciences","sponsor_name_normalized":"gilead sciences","query_used":"Gilead","country_code":"USA","n_starts_trailing12m":40,"n_starts_prior12m":50,"n_phase3_trailing12m":5,"n_phase3_prior12m":8,"velocity_pct":-20.0,"phase3_velocity_pct":-37.5,"pipeline_score":38.78,"pipeline_rank":26,"momentum_flag":"declining","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Gilead&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"65fb63c6411ebec4"},{"as_of":"2026-09-01","sponsor_name":"Regeneron","sponsor_name_normalized":"regeneron","query_used":"Regeneron","country_code":"USA","n_starts_trailing12m":79,"n_starts_prior12m":61,"n_phase3_trailing12m":22,"n_phase3_prior12m":13,"velocity_pct":29.51,"phase3_velocity_pct":69.23,"pipeline_score":52.71,"pipeline_rank":8,"momentum_flag":"growing","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Regeneron&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"c2be576c9c13a5b1"},{"as_of":"2026-09-01","sponsor_name":"Moderna","sponsor_name_normalized":"moderna","query_used":"ModernaTX","country_code":"USA","n_starts_trailing12m":11,"n_starts_prior12m":15,"n_phase3_trailing12m":2,"n_phase3_prior12m":5,"velocity_pct":-26.67,"phase3_velocity_pct":-60.0,"pipeline_score":24.68,"pipeline_rank":41,"momentum_flag":"declining","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=ModernaTX&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"96071efb77dcffb1"},{"as_of":"2026-09-01","sponsor_name":"Biogen","sponsor_name_normalized":"biogen","query_used":"Biogen","country_code":"USA","n_starts_trailing12m":15,"n_starts_prior12m":15,"n_phase3_trailing12m":3,"n_phase3_prior12m":4,"velocity_pct":0.0,"phase3_velocity_pct":-25.0,"pipeline_score":31.41,"pipeline_rank":32,"momentum_flag":"stable","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Biogen&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"7d3c88663eeb0393"},{"as_of":"2026-09-01","sponsor_name":"Vertex Pharmaceuticals","sponsor_name_normalized":"vertex pharmaceuticals","query_used":"Vertex Pharmaceuticals","country_code":"USA","n_starts_trailing12m":14,"n_starts_prior12m":20,"n_phase3_trailing12m":2,"n_phase3_prior12m":4,"velocity_pct":-30.0,"phase3_velocity_pct":-50.0,"pipeline_score":26.63,"pipeline_rank":39,"momentum_flag":"declining","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Vertex+Pharmaceuticals&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"7c693d8e3af1bed1"},{"as_of":"2026-09-01","sponsor_name":"Incyte","sponsor_name_normalized":"incyte","query_used":"Incyte","country_code":"USA","n_starts_trailing12m":40,"n_starts_prior12m":40,"n_phase3_trailing12m":4,"n_phase3_prior12m":10,"velocity_pct":0.0,"phase3_velocity_pct":-60.0,"pipeline_score":41.51,"pipeline_rank":21,"momentum_flag":"stable","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Incyte&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"42d21a097607e5c3"},{"as_of":"2026-09-01","sponsor_name":"Genentech","sponsor_name_normalized":"genentech","query_used":"Genentech","country_code":"USA","n_starts_trailing12m":38,"n_starts_prior12m":39,"n_phase3_trailing12m":2,"n_phase3_prior12m":1,"velocity_pct":-2.56,"phase3_velocity_pct":100.0,"pipeline_score":40.62,"pipeline_rank":22,"momentum_flag":"stable","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Genentech&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"fd918dea8a4e0766"},{"as_of":"2026-09-01","sponsor_name":"Janssen","sponsor_name_normalized":"janssen","query_used":"Janssen","country_code":"USA","n_starts_trailing12m":71,"n_starts_prior12m":49,"n_phase3_trailing12m":16,"n_phase3_prior12m":14,"velocity_pct":44.9,"phase3_velocity_pct":14.29,"pipeline_score":53.67,"pipeline_rank":5,"momentum_flag":"growing","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Janssen&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"e638d450faf6bb5d"},{"as_of":"2026-09-01","sponsor_name":"Viatris","sponsor_name_normalized":"viatris","query_used":"Viatris","country_code":"USA","n_starts_trailing12m":13,"n_starts_prior12m":3,"n_phase3_trailing12m":1,"n_phase3_prior12m":1,"velocity_pct":333.33,"phase3_velocity_pct":0.0,"pipeline_score":70.88,"pipeline_rank":1,"momentum_flag":"surging","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Viatris&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"5ef4190913447fb3"},{"as_of":"2026-09-01","sponsor_name":"Organon","sponsor_name_normalized":"organon","query_used":"Organon","country_code":"USA","n_starts_trailing12m":1,"n_starts_prior12m":3,"n_phase3_trailing12m":1,"n_phase3_prior12m":0,"velocity_pct":-66.67,"phase3_velocity_pct":null,"pipeline_score":0.0,"pipeline_rank":47,"momentum_flag":"contracting","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Organon&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"19a8773f09a022c9"},{"as_of":"2026-09-01","sponsor_name":"Abbott","sponsor_name_normalized":"abbott","query_used":"Abbott","country_code":"USA","n_starts_trailing12m":41,"n_starts_prior12m":47,"n_phase3_trailing12m":1,"n_phase3_prior12m":0,"velocity_pct":-12.77,"phase3_velocity_pct":null,"pipeline_score":40.03,"pipeline_rank":24,"momentum_flag":"declining","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Abbott&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"48cdf7523559c574"},{"as_of":"2026-09-01","sponsor_name":"Boston Scientific","sponsor_name_normalized":"boston scientific","query_used":"Boston Scientific","country_code":"USA","n_starts_trailing12m":43,"n_starts_prior12m":39,"n_phase3_trailing12m":0,"n_phase3_prior12m":1,"velocity_pct":10.26,"phase3_velocity_pct":-100.0,"pipeline_score":43.66,"pipeline_rank":20,"momentum_flag":"growing","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Boston+Scientific&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"e202ee7d45ccd45e"},{"as_of":"2026-09-01","sponsor_name":"Edwards Lifesciences","sponsor_name_normalized":"edwards lifesciences","query_used":"Edwards Lifesciences","country_code":"USA","n_starts_trailing12m":6,"n_starts_prior12m":9,"n_phase3_trailing12m":0,"n_phase3_prior12m":0,"velocity_pct":-33.33,"phase3_velocity_pct":null,"pipeline_score":17.99,"pipeline_rank":46,"momentum_flag":"declining","source_url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Edwards+Lifesciences&filter.advanced=AREA%5BStartDate%5DRANGE%5B09%2F01%2F2025%2C08%2F31%2F2026%5D&countTotal=true&pageSize=1&fields=NCTId","row_hash":"075ccded5696a1ee"}]